Data / Form D filings / Nova Mentis Life Science Corp.
Nova Mentis Life Science Corp.: Form D filings
Nova Mentis Life Science Corp., a health care company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC between 2016 and 2020. The latest, on August 4, 2020, reports $12,170 sold of a $12,170 offering to 1 investor.
Find out what Nova Mentis Life Science Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700-838 WEST HASTINGS STREET, Vancouver, British Columbia, Canada, V6C 0
- Phone
- (778) 819-0244
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1689231
The full lists. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2020 | New notice | $12,170 | $12,170 | $0 | 1 | Jun 23, 2020 | sec.gov |
| Feb 5, 2018 | New notice | $88,297 | $88,297 | $0 | 6 | Jan 22, 2018 | sec.gov |
| Nov 4, 2016 | New notice | $87,543 | $87,543 | $0 | 2 | Oct 19, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jamie Robinson | Executive Officer | |
| William Rascan | Executive Officer, Director | |
| Kelly Pladson | Executive Officer | |
| Dr. Aylia Mohammadi | Director | |
| Steven Feldman | Director |
Every Form D from the week of Aug 3, 2020 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Nova Mentis Life Science Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.